Taken together, the in vivo and in vitro results demonstrate that the loss of p300 enhanced the self-renewal and proliferation of Tet2-deficient HSPCs, increasing the bone marrow HSPC pool and accelerating leukemia development of the doubly deficient mice. This evidence concerns the gene EP300 and leukemia.